Department of Gastroenterological Surgery, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
Dig Surg. 2017;34(6):447-454. doi: 10.1159/000455295. Epub 2017 Mar 21.
BACKGROUND/AIMS: Resection of the liver is the standard therapeutic approach for patients with hepatic metastasis and is the only therapy with curative potential. The optimal timing of surgical resection for synchronous metastases has remained controversial.
From January 1993 to December 2008, our strategy has been to use simultaneous resection for resectable synchronous colorectal and liver metastases. During this period, 115 patients underwent simultaneous colorectal and hepatic resection. We evaluated the short-term outcomes of these patients by reviewing operative and perioperative clinical data.
In patients with simultaneous resection, there was no evidence of colorectal complications associated with major hepatectomy or no evidence of hepatic complications related to rectal resection. But increased hepatic complications were apparent with major hepatectomy compared with minor hepatectomy (44 vs. 7.2%, p < 0.001) and patients with rectal resection had increased colorectal complications (23% in the rectal resection vs. 5.3% in the colectomy group, p = 0.034).
Simultaneous major hepatectomy and rectal resection can increase the hepatic or colorectal morbidity, respectively. These patients may be considered for staged resections.
背景/目的:肝切除术是肝转移患者的标准治疗方法,也是唯一具有治愈潜力的治疗方法。对于同步转移,手术切除的最佳时机仍存在争议。
自 1993 年 1 月至 2008 年 12 月,我们的策略是对可切除的结直肠和肝同步转移采用同时切除。在此期间,有 115 例患者接受了同时的结直肠和肝切除术。我们通过回顾手术和围手术期临床数据来评估这些患者的短期结果。
在同时切除的患者中,没有证据表明与肝切除术相关的结直肠并发症,也没有证据表明与直肠切除术相关的肝并发症。但与小肝切除术相比,大肝切除术的肝并发症明显增加(44%比 7.2%,p<0.001),并且直肠切除术患者的结直肠并发症增加(直肠切除术组为 23%,结肠切除术组为 5.3%,p=0.034)。
同时进行大肝切除术和直肠切除术可能会分别增加肝或结直肠的发病率。这些患者可能需要分期切除。